Pieris Pharmaceuticals, Inc. announced that Darlene Deptula-Hicks has submitted her resignation, effective February 7, 2017, to pursue other interests. While the company conducts an executive search for a permanent successor, Lance Thibault of Danforth Advisors, is assuming the role of Acting Chief Financial Officer. Ms. Darlene Deptula-Hicks joined Pieris Pharmaceuticals as Senior Vice President and Chief Financial Officer in September 2015.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.53 USD | -7.38% |
|
-22.26% | -55.15% |
1st Jan change | Capi. | |
---|---|---|
-55.15% | 9.31M | |
+20.95% | 127B | |
+23.00% | 116B | |
+25.15% | 27.69B | |
-19.75% | 19.62B | |
-16.57% | 16.26B | |
-16.56% | 15.49B | |
+11.19% | 14.81B | |
-46.65% | 14.39B | |
+57.74% | 14.11B |
- Stock Market
- Equities
- PIRS Stock
- News Pieris Pharmaceuticals, Inc.
- Pieris Pharmaceuticals, Inc. Announces Management Changes